Skip to content
★ Sign in to follow
CT

Chemokine Therapeutics Corp Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Salari Hassan, was filed 20 Jan 2009.

Chemokine Therapeutics Corp: what insiders have been doing

Chemokine Therapeutics Corp is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Chemokine Therapeutics Corp has published a filing in the past twelve months. The most recent one dates from 20 January 2009.

Looking back to 2008, when coverage begins, insiders filed 14 purchases and 4 sales.

Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
19
Thresholds
n/a
Buy Volume
€242,032
14 ops. · all time
Sell Volume
€2,785
4 ops. · all time

Financial data

· cache

Last declaration on 20 January 2009
Declarations19 total
  • ▲
    10% OwnerExecutives
    2,569 USD0SEC
    256,900 shares@ US$0.01Common StockSEC:0001176256-09-000044:0
    Canonical exit: 15 Apr 2009 (T+90)
  • ▲
    10% OwnerExecutives
    4,718 USD0SEC
    314,500 shares@ US$0.015Common StockSEC:0001176256-09-000026:0
    Canonical exit: 9 Apr 2009 (T+90)
  • ▲
    10% OwnerExecutives
    340 USD0SEC
    34,000 shares@ US$0.01Common StockSEC:0001176256-09-000026:1
    Canonical exit: 12 Apr 2009 (T+90)
  • ▲
    10% OwnerExecutives
    8,500 USD0SEC
    100,000 shares@ US$0.085Common StockSEC:0001176256-08-000997:0
    Canonical exit: 25 Nov 2008 (T+90)
  • ▲
    10% OwnerExecutives
    77,400 USD0SEC
    1,290,000 shares@ US$0.06Common StockSEC:0001176256-08-000997:1
    Canonical exit: 25 Nov 2008 (T+90)
  • ▲
    V.P. Corporate CommunicationsExecutives
    2,550 USD0SEC
    30,000 shares@ US$0.085Common StockSEC:0001176256-08-000989:0
    Canonical exit: 20 Nov 2008 (T+90)
  • ▲
    V.P. Corporate CommunicationsExecutives
    1,625 USD0SEC
    25,000 shares@ US$0.065Common StockSEC:0001176256-08-000989:1
    Canonical exit: 20 Nov 2008 (T+90)
  • ▼
    V.P. Corporate CommunicationsExecutives
    160 USD0SEC
    1,450 shares@ US$0.11Common StockSEC:0001176256-08-000989:2
  • ▼
    V.P. Corporate CommunicationsExecutives
    1,000 USD0SEC
    10,000 shares@ US$0.10Common StockSEC:0001176256-08-000989:3
  • ▼
    V.P. Corporate CommunicationsExecutives
    920 USD0SEC
    9,200 shares@ US$0.10Common StockSEC:0001176256-08-000989:4
  • ▼
    V.P. Corporate CommunicationsExecutives
    2,000 USD0SEC
    25,000 shares@ US$0.08Common StockSEC:0001176256-08-000989:5
  • ▲
    DirectorExecutives
    100,000 USD0SEC
    666,666 shares@ US$0.15Common StockSEC:0001176256-08-000790:0
    Canonical exit: 11 Sept 2008 (T+90)
  • ▲
    Chief Scientific OfficerExecutives
    12,000 USD0SEC
    80,000 shares@ US$0.15Common StockSEC:0001176256-08-000791:0
    Canonical exit: 11 Sept 2008 (T+90)
  • ▲
    Chief Scientific OfficerExecutives
    9,000 USD0SEC
    50,000 shares@ US$0.18Common stockSEC:0001179110-08-007881:0
    Canonical exit: 15 Jul 2008 (T+90)
  • ▲
    Pres./Chief Scientific OfficerExecutives
    8,000 USD0SEC
    50,000 shares@ US$0.16Common stockSEC:0001179110-08-007655:0
    Canonical exit: 9 Jul 2008 (T+90)
  • ◆
    Pres./Chief Scientific OfficerExecutives
    200,151 USD0SEC
    247,100 shares@ US$0.81Common stockSEC:0001176256-08-000142:0
  • ▲
    Pres./Chief Scientific OfficerExecutives
    62,500 USD0SEC
    312,500 shares@ US$0.20Common StockSEC:0001176256-08-000147:0
    Canonical exit: 7 May 2008 (T+90)
  • ▲
    DirectorExecutives
    60,000 USD0SEC
    300,000 shares@ US$0.20Common stockSEC:0001176256-08-000145:0
    Canonical exit: 7 May 2008 (T+90)
  • ▲
    Chief Financial OfficerExecutives
    10,000 USD0SEC
    50,000 shares@ US$0.20Common stockSEC:0001176256-08-000146:0
    Canonical exit: 7 May 2008 (T+90)

19 of 19 declarations

About Chemokine Therapeutics Corp

Chemokine Therapeutics Corp is a company focused on developing treatments based on chemokines for serious diseases. It is listed on the NASDAQ.